Results 41 to 50 of about 4,657,009 (154)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

Research and Practice in Thrombosis and Haemostasis, 2022
Background Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded)
Emmanuel J. Favaloro, Leonardo Pasalic
doaj   +1 more source

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background For more than a decade, guidelines have recommended a limited 3 months of anticoagulation for the treatment of provoked venous thromboembolism (VTE).
Elizabeth Joyce, Brian Haymart, Xiaowen Kong, Mona A. Ali, Mara Carrigan, Scott Kaatz, Vinay Shah, Eva Kline‐Rogers, Jay Kozlowski, James B. Froehlich, Geoffrey D. Barnes   +10 more
doaj   +1 more source

Clinical characteristics and oral anticoagulant treatment.

, 2022
Clinical characteristics and oral anticoagulant treatment.
Christina Christersson (4733853), Claes Held (48065), Angelo Modica (11944015), Gorav Batra (5801282), Johan Westerbergh (11944018)   +4 more
core   +1 more source

Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background A rapid shift has occurred from vitamin K antagonists toward direct oral anticoagulants, which have a lower risk of intracerebral hemorrhage (ICH). However, effects on clinical outcomes after ICH are understudied.
Mattias Tallroth, Ruzan Udumyan, András Büki, Mia von Euler   +3 more
doaj   +1 more source

PREVENTION OF STROKE IN ATRIAL FIBRILLATION: THE APPROACHES TO THE CHOICE OF ANTICOAGULANT, DEPENDING ON AGE

Евразийский Кардиологический Журнал, 2016
SUMMERY The main objective of the management of patients with atrial fibrillation (AF) is an effective prevention of ischemic stroke. For this purpose indirect and direct oral anticoagulants may be used.
A. V. Ardashev, I. V. Zotova
doaj   +1 more source

In‐Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background We sought to examine patient characteristics, peri‐infarction invasive and pharmacologic management, and in‐hospital major bleeding in myocardial infarction patients with atrial fibrillation or flutter, based on home anticoagulant use. Methods
Dmitriy N. Feldman, Tracy Y. Wang, Anita Y. Chen, Rajesh V. Swaminathan, Luke K. Kim, S. Chiu Wong, Robert M. Minutello, Geoffrey Bergman, Harsimran S. Singh, Christopher Madias   +9 more
doaj   +1 more source

Laboratory monitoring of warfarin in the era of direct oral anticoagulants

, 2015
Laboratory monitoring of warfarin in the era of direct oral ...
LIPPI, Giuseppe, Favaloro, Emmanuel J.
core   +1 more source

Trends in direct oral anticoagulant management in patients undergoing cardiac implantable electronic device procedures [PDF]

, 2017
In many parts of the world, there are no consensus guidelines regarding direct oral anticoagulant (DOAC) management for cardiac implantable electronic device (CIED) procedures.
Waddell, Christen R.
core   +1 more source

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)

Journal of Arrhythmia, 2017
Background: To obtain a perspective of the current status of catheter ablation for the cure of atrial fibrillation, the Japanese Heart Rhythm Society conducted a nationwide survey: the Japanese Catheter Ablation Registry of Atrial Fibrillation.
Yuji Murakawa, MD, Akihiko Nogami, MD, Morio Shoda, MD, Koichi Inoue, MD, Shigeto Naito, MD, Koichiro Kumagai, MD, Yasushi Miyauchi, MD, Teiichi Yamane, MD, Norishige Morita, MD, Hideo Mitamura, MD, Ken Okumura, MD, Kenzo Hirao, MD   +11 more
doaj   +1 more source

Safe chest tube placement in a patient with tension pneumothorax receiving rivaroxaban therapy for non-valvular atrial fibrillation

Monaldi Archives for Chest Disease, 2020
The number of patients treated with direct oral anticoagulants is increasing worldwide. Although bleeding complications associated with direct oral anticoagulants are lower than those associated with vitamin K antagonists, the increased number of ...
Alessandro Cipriano, Matteo Parollo, Ester Taurino, Elena Venturi, Massimo Santini   +4 more
doaj   +1 more source